Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Orchestra BioMed Holdings Inc.
OBIOCurrent price
5.61 USD
-0.24 USD (-4.10%)
Last closed
5.79 USD
Company
–
ISIN
US68572M1062
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
253 424 816 USD
Yield for 12 month
-9.37 %
1Y
3Y
5Y
10Y
15Y
OBIO
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania. Address: 150 Union Square Drive, New Hope, PA, United States, 18938
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.6 USDP/E ratio
–Dividend Yield
–Current Year
+2 760 000 USD
Last Year
+3 533 000 USD
Current Quarter
+778 000 USD
Last Quarter
+620 000 USD
Current Year
+2 430 500 USD
Last Year
+3 211 000 USD
Current Quarter
+660 000 USD
Last Quarter
+512 000 USD
Key Figures OBIO
1 year
3 years
5 years
10 years
EBITDA
-57 996 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.75 %
PEG Ratio
–
Return On Equity TTM
-83.22 %
Wall Street Target Price
15.6 USD
Revenue TTM
2 079 000 USD
Book Value
1.23 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-15 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.56 USD
Diluted Eps TTM
-1.56 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OBIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation OBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
91.4256
Price Sales TTM
121.8975
Enterprise Value EBITDA
-1.8118
Price Book MRQ
5.7519
Financials OBIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OBIO
For 52 weeks
4.22 USD
11.69 USD
50 Day MA
7.1 USD
Shares Short Prior Month
963 595
200 Day MA
6.71 USD
Short Ratio
13.68
Shares Short
1 060 640
Short Percent
5.01 %
BeatStart